By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer said after the close of the market Tuesday that it has reached an agreement to sell its Illumination and Detection Solutions business to private equity group Veritas Capital Fund III for around $500 million in cash.

PerkinElmer said that the divestiture would enable it to reinvest in its core Human Health and Environmental Health businesses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.